US Patent 10927161 Methods for modulating an immune response
Patent 10927161 was granted and assigned to Cue Biopharma on February, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10927161 Methods for modulating an immune response
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
